Article
Canine Histiocytic and Hemophagocytic Histiocytic Sarcomas Display KRAS and Extensive PTPN11/SHP2 Mutations and Respond In Vitro to MEK Inhibition by Cobimetinib.
Genes - 9 Aug 2024
Yang Ya-Ting, Engleberg Alexander I, Kapoor Ishana, Kitagawa Keita, Hilburger Sara A, Thaiwong-Nebelung Tuddow, Yuzbasiyan-Gurkan Vilma
Abstract excerpt
Histiocytic sarcoma (HS) is a rare and highly aggressive cancer in humans and dogs. In dogs, it has a high prevalence in certain breeds, such as Bernese mountain dogs (BMDs) and flat-coated retrievers. Hemophagocytic histiocytic sarcoma (HHS) is a unique form of HS that presents with erythrophagocytosis. Due to its rareness, the study of HHS is very limited, and mutations in canine HHS patients have not been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
